The purpose of this RFA was to fund grants that focused on the development and testing of innovative, feasible, and effective models of care for adult survivors of cancer who are transitioning from active treatment to follow-up care. Specifically, grants proposed a multi-level intervention aimed at enhancing communication, collaboration, and coordination among oncology and non-oncology providers to improve survivor outcomes.
Blue Ribbon Panel Recommendation
The Cancer Moonshot℠ was designed to accelerate efforts to prevent, diagnose, and treat cancer and achieve 10 years of progress in 5 years. This RFA is responsive to Blue Ribbon Panel Recommendation F, Minimize cancer treatment’s debilitating side effects; Accelerate the clinical adoption of integrated systems to monitor patient-reported symptoms and provide decision support using implementation science approaches and evidence-based symptom management guidelines.
|Grant Number||Project Title||Institution||Principal Investigator(s)|
|R01CA249460||City of Hope, Harvard University||Saro Armenian;
|R01CA249419||Kaiser Foundation||Erin Hahn|
|R01CA249467||University of Rochester||Supriya Mohile;
|R01CA249568||Duke University||Kevin Oeffinger;
|R01CA249501||City of Hope||Virginia Sun|